Diverse responses to EGFR-TKIs in patients with concurrent germline and somatic EGFR mutations

Lung Cancer. 2021 Dec:162:207-209. doi: 10.1016/j.lungcan.2021.10.022. Epub 2021 Nov 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • ErbB Receptors / genetics
  • Germ Cells
  • Humans
  • Lung Neoplasms*
  • Mutation
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors